Nicotine use in schizophrenia: the self medication hypotheses
about
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR functionThe case in favor of E-cigarettes for tobacco harm reductionCircuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaSchizophrenia, hypocretin (orexin), and the thalamocortical activating systemSmoking cessation and reduction in people with chronic mental illnessType III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit componentsAssociations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and ChildrenEffects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in ratsnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Targeting Functional Biomarkers in Schizophrenia with Neuroimaging.Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats.Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersAcoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.Inhibitory learning is modulated by nicotinic acetylcholine receptors.Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.Smoking in schizophrenic patients: A critique of the self-medication hypothesis.Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patientsACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.Effects of intravenous nicotine on prepulse inhibition in smokers and non-smokers: relationship with familial smoking.Mismatch negativity latency and cognitive function in schizophrenia.Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice.Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in ratsGenetic dissection of medial habenula-interpeduncular nucleus pathway function in mice.Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.Unusual effects of nicotine as a psychostimulant on ambulatory activity in miceSensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking statusHippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.Molecular targets for treating cognitive dysfunction in schizophrenia.Smoking, Genetics and Schizophrenia: Evidence for Self Medication.Does tobacco use cause psychosis? Systematic review and meta-analysisResting-state functional connectivity and nicotine addiction: prospects for biomarker developmentCNTRICS final task selection: long-term memory.Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls.Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.Gender differences in the association between pre-adolescent smoking initiation and emotional or behavioural problems.
P2860
Q24308763-6C368F9B-0A89-44BE-A36A-E78B480F6E41Q24563521-608A3B47-FE74-4CBC-A65F-8309BE74DF02Q24646206-227D1598-70CB-4F61-9154-6D152CDFFD63Q24653910-A50CA73C-6EB7-4871-8771-D087983178A4Q26782639-DD434C5D-DC98-4EAA-A16B-41919F1493F9Q28585466-A365C612-2291-4D44-8C95-E8967D1CBB6CQ28650412-5B0C8510-5678-4D95-B021-C8ED03865E74Q30354969-A6BCEF95-03FB-4E02-8BED-BC480EBC4B74Q30362464-7CE46242-7EA3-4A66-8FA9-D12985756D61Q30366697-769C5735-B70C-4F32-976B-EA90AE8F4486Q30371377-E1B03A50-B6FC-4F9D-90B0-EE72BFED889BQ30372351-A86CE76E-63EA-446D-B0FE-DE182340AF4BQ30373333-F3E30F4A-B046-4326-9935-BE2D9AE6B0F2Q30392492-0E0105B5-8B17-4D44-BB80-17E1C0F218A3Q30415168-93A95000-8022-446E-A682-31F6A2BE4DE2Q30416030-7E2BFFE4-7B4F-4196-9426-9623C05DEACAQ30425458-14055F27-175C-4272-B2B0-1C4C95D22379Q30429221-4B743749-40CA-4CAE-AEE2-2169C6616D68Q30432102-7F41F541-008E-47AA-8C5F-E99AF679C971Q30439908-FF037146-4DD6-49C9-A473-6BA9989CBCE1Q30443234-3B0200B4-C38D-4E71-9EE8-7E0E5FEDA9EDQ30445192-62AC55A4-199C-41CE-BEEE-F085DBB3E576Q30455777-80709EFA-AD00-4CD4-A873-71153705C69BQ30457436-C00B1624-F058-4EDC-9CB2-C90D55BC554DQ30462575-79C168B5-2164-4FBC-B977-BB94F050F9D4Q30468347-5E0BF84C-BC07-4A3E-A43C-0F9F04FAADE4Q30475351-A7220144-36B9-4096-9096-77A6BE7C579EQ30479419-291514DC-1CAD-4C2D-8221-2E512B5FD144Q30488467-68831F9D-D75B-4502-BC01-E66528924433Q30489404-8DB67E7B-B14C-42A6-AF00-20500EBBC4A3Q30489625-F2E2EF9C-5C99-4CDD-AC59-7BDE428311CCQ30491310-12BFAF1B-C2A1-4CEE-A502-CC5236911343Q30491841-6ABE784B-2FB0-47FA-A259-1373B9C1FF10Q30694281-F7F01341-0F34-4C32-8577-3D6430ECB35DQ30992161-F07E8834-42AD-4FE1-A1D2-C392CE655D6CQ33377410-CCEE22AF-2358-41FF-823D-F697886D3B08Q33598688-5430F7E2-41C0-4E54-A1FF-897D5335D7D0Q33644537-5F79E05A-F213-4835-8138-445610545CD6Q33684431-27FA7D1A-6238-45F3-841D-C704F0F08800Q33721332-EBD56B6A-2FE8-4DE2-9384-90B6A993205A
P2860
Nicotine use in schizophrenia: the self medication hypotheses
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nicotine use in schizophrenia: the self medication hypotheses
@ast
Nicotine use in schizophrenia: the self medication hypotheses
@en
Nicotine use in schizophrenia: the self medication hypotheses
@nl
type
label
Nicotine use in schizophrenia: the self medication hypotheses
@ast
Nicotine use in schizophrenia: the self medication hypotheses
@en
Nicotine use in schizophrenia: the self medication hypotheses
@nl
prefLabel
Nicotine use in schizophrenia: the self medication hypotheses
@ast
Nicotine use in schizophrenia: the self medication hypotheses
@en
Nicotine use in schizophrenia: the self medication hypotheses
@nl
P3181
P1476
Nicotine use in schizophrenia: the self medication hypotheses
@en
P2093
Peggy Postma
P304
P3181
P356
10.1016/J.NEUBIOREV.2005.02.006
P407
P50
P577
2005-01-01T00:00:00Z